CD44 and breast cancer: In the current study, the effects of SATB1 overexpression or knockdown were investigated on the stem cell populations in the breast cancer cell lines MCF-7 or BT-549, respectively, by assessment of in vitro mammosphere formation and CD44+/CD21− expression, and observation of tumor formation in SCID mice.